The FDA approved Sublocade, Indivior’s once-monthly buprenophine injection, to treat opioid use disorder in adults with moderate-to-severe addiction. Here are four things to know. 1. Buprenophine for ...
Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The company revealed its results at this week’s Conference on Retroviruses and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback